146 related articles for article (PubMed ID: 38195936)
1. Why population pharmacokinetic studies are instrumental to boost clinical research in neonates, and suggestions on how clinicians should assess these papers.
Li Y; Allegaert K
Pediatr Res; 2024 Apr; 95(5):1181-1183. PubMed ID: 38195936
[No Abstract] [Full Text] [Related]
2. Predictive Performance of Population Pharmacokinetic Models for Amikacin in Term Neonates.
Matcha S; Dillibatcha J; Raju AP; Chaudhari BB; Moorkoth S; Lewis LE; Mallayasamy S
Paediatr Drugs; 2023 May; 25(3):365-375. PubMed ID: 36943583
[TBL] [Abstract][Full Text] [Related]
3. Lidocaine (lignocaine) dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures.
van den Broek MP; Huitema AD; van Hasselt JG; Groenendaal F; Toet MC; Egberts TC; de Vries LS; Rademaker CM
Clin Pharmacokinet; 2011 Jul; 50(7):461-9. PubMed ID: 21651313
[TBL] [Abstract][Full Text] [Related]
4. Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial.
Bekker A; Salvadori N; Rabie H; du Toit S; Than-In-At K; Groenewald M; Cressey R; Nielsen J; Capparelli EV; Lallemant M; Cotton MF; Cressey TR;
Lancet HIV; 2024 Feb; 11(2):e86-e95. PubMed ID: 38296364
[TBL] [Abstract][Full Text] [Related]
5. Clinical Pharmacokinetic Studies in Pregnant Women and the Relevance of Pharmacometric Tools.
Dallmann A; Mian P; Van den Anker J; Allegaert K
Curr Pharm Des; 2019; 25(5):483-495. PubMed ID: 30894099
[TBL] [Abstract][Full Text] [Related]
6. Identifying the data elements and functionalities of clinical decision support systems to administer medication for neonates and pediatrics: a systematic literature review.
Norouzi S; Galavi Z; Ahmadian L
BMC Med Inform Decis Mak; 2023 Nov; 23(1):263. PubMed ID: 37974195
[TBL] [Abstract][Full Text] [Related]
7. Suggestions for Model-Informed Precision Dosing to Optimize Neonatal Drug Therapy.
Euteneuer JC; Kamatkar S; Fukuda T; Vinks AA; Akinbi HT
J Clin Pharmacol; 2019 Feb; 59(2):168-176. PubMed ID: 30204236
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome.
Ng CM; Dombrowsky E; Lin H; Erlich ME; Moody DE; Barrett JS; Kraft WK
Pharmacotherapy; 2015 Jul; 35(7):670-80. PubMed ID: 26172282
[TBL] [Abstract][Full Text] [Related]
9. What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studies.
Jacobs TG; Schouwenburg S; Penazzato M; Archary M; Ruel TD; van den Anker J; Burger DM; Cressey TR; Abrams EJ; Lyall H; Bekker A; Colbers A; ;
Lancet HIV; 2022 Sep; 9(9):e649-e657. PubMed ID: 35863363
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.
Roberts JK; Stockmann C; Constance JE; Stiers J; Spigarelli MG; Ward RM; Sherwin CM
Clin Pharmacokinet; 2014 Jul; 53(7):581-610. PubMed ID: 24871768
[TBL] [Abstract][Full Text] [Related]
11. Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants.
Zhao Y; Yao BF; Kou C; Xu HY; Tang BH; Wu YE; Hao GX; Zhang XP; Zhao W
Front Pharmacol; 2020; 11():14. PubMed ID: 32116695
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin: Predictive Performance of a Population Pharmacokinetic Model and Optimal Dose in Neonates and Young Infants.
Marsot A; Vialet R; Boulamery A; Bruguerolle B; Simon N
Clin Pharmacol Drug Dev; 2012 Oct; 1(4):144-51. PubMed ID: 27121456
[TBL] [Abstract][Full Text] [Related]
13. Current and future physiologically based pharmacokinetic (PBPK) modeling approaches to optimize pharmacotherapy in preterm neonates.
Allegaert K; Abbasi MY; Annaert P; Olafuyi O
Expert Opin Drug Metab Toxicol; 2022 May; 18(5):301-312. PubMed ID: 35796504
[TBL] [Abstract][Full Text] [Related]
14. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.
Hirt D; Van Overmeire B; Treluyer JM; Langhendries JP; Marguglio A; Eisinger MJ; Schepens P; Urien S
Br J Clin Pharmacol; 2008 May; 65(5):629-36. PubMed ID: 18307541
[TBL] [Abstract][Full Text] [Related]
15. A predictive pharmacokinetic/pharmacodynamic model of fentanyl for analgesia/sedation in neonates based on a semi-physiologic approach.
Encinas E; Calvo R; Lukas JC; Vozmediano V; Rodriguez M; Suarez E
Paediatr Drugs; 2013 Jun; 15(3):247-57. PubMed ID: 23657896
[TBL] [Abstract][Full Text] [Related]
16. Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study.
Bekker A; Capparelli EV; Violari A; Cotton MF; Cababasay M; Wang J; Mathiba R; Wiesner L; Wiznia A; Samson P; Browning R; Moye J; Nakwa FL; Decloedt E; Rabie H; Mirochnick M; Cressey TR;
Lancet HIV; 2022 Jan; 9(1):e24-e31. PubMed ID: 34883066
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics and dosing optimization of azlocillin in neonates with early-onset sepsis: a real-world study.
Wu YE; Wang T; Yang HL; Tang BH; Kong L; Li X; Gao Q; Li X; Yao BF; Shi HY; Huang X; Wang WQ; Jacqz-Aigrain E; Allegaert K; van den Anker J; Tian XY; Zhao W
J Antimicrob Chemother; 2021 Feb; 76(3):699-709. PubMed ID: 33188385
[TBL] [Abstract][Full Text] [Related]
18. Oral and Intravenous Amoxicillin Dosing Recommendations in Neonates: A Pooled Population Pharmacokinetic Study.
Keij FM; Schouwenburg S; Kornelisse RF; Preijers T; Mir F; Degraeuwe P; Stolk LM; van Driel A; Kenter S; van der Sluijs J; Heidema J; den Butter PCP; Reiss IKM; Allegaert K; Tramper-Stranders GA; Koch BCP; Flint RB
Clin Infect Dis; 2023 Nov; 77(11):1595-1603. PubMed ID: 37757471
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
Lanao JM; Calvo MV; Mesa JA; Martín-Suárez A; Carbajosa MT; Miguelez F; Domínguez-Gil A
J Antimicrob Chemother; 2004 Jul; 54(1):193-8. PubMed ID: 15150171
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants.
Zhou J; Jiang L; Zhang ZL; Wang ZR; Zhang YX; Lin X; Tang BH; Yao BF; Guo ZX; Yang JJ; Van Den Anker J; Wu YE; Zhao W
J Antimicrob Chemother; 2022 Jul; 77(8):2238-2244. PubMed ID: 35662337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
